HomeVoriconazoleVoriconazole + Lumacaftor And Ivacaftor

Does Voriconazole Interact with Lumacaftor And Ivacaftor?

Voriconazole and Lumacaftor And Ivacaftor have a moderate drug interaction according to U.S. FDA drug labeling data. Strong CYP3A inhibitor may increase ivacaftor exposure. Dosage adjustment recommended when initiating ORKAMBI. The mechanism involves cyp3a inhibition. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Voriconazole Class
Azole Antifungal
Lumacaftor And Ivacaftor Class
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Voriconazole and Lumacaftor And Ivacaftor occurs because cyp3a inhibition. Clinically, this means strong cyp3a inhibitor may increase ivacaftor exposure. dosage adjustment recommended when initiating orkambi. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Voriconazole and your doctor is considering prescribing Lumacaftor And Ivacaftor (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Voriconazole+💊 Lumacaftor And Ivacaftor(Orkambi)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Azole Antifungal
Drug B class
Cystic Fibrosis Transmembrane Conductance Regulator Potentiator
Source
NLP:lumacaftor and ivacaftor

What this means in plain English

Strong CYP3A inhibitor may increase ivacaftor exposure. Dosage adjustment recommended when initiating ORKAMBI.

What the FDA label says

"CYP3A inhibition"

📖 Source: NLP:lumacaftor and ivacaftor

Share this result:XFacebookWhatsAppReddit
Add more drugs
Check Voriconazole and Lumacaftor And Ivacaftor against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.